Zenas BioPharma, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zenas BioPharma, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $449.61M.
- Zenas BioPharma, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $449.61M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $449.61M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $449.61M 10-Q · filed 2024-11-12 |